Inspiring new hope

Driven by a passion to make a lasting, positive impact on global health, FloraWorks is unlocking the untapped potential of cannabinoids to improve lives.

We stand at the forefront of cannabinoid science, pioneering the discovery and development of rare and novel cannabinoid-based therapeutics that offer new possibilities for wellness and medicine.

Woman in a supplement store holding a jar of sleep softgels made with TruCBN™

Our vision

At FloraWorks, we believe non-intoxicating cannabinoids belong on the shelves of mainstream health and wellness retailers backed by gold-standard scientific validation.

We are reshaping perceptions through evidence: proving efficacy and safety with the same rigor used in pharmaceutical and dietary ingredient development.

Our work is guided by a single belief: when science meets purpose, new hope emerges for people whose needs have not been met by conventional medicine.

Our research & development

GMP Certification

The gold standard of manufacturing excellence.

ISO 9001 Certification

Quality management you can rely on

Clinically Validated Efficacy

Peer-reviewed, published research from a 1000+ person cohort.

Comprehensive Safety Data

Validated toxicology and stability testing.

Guided by experts

TruCBN™ is supported by a Scientific Advisory Board spanning sleep medicine, clinical development and cannabinoid science. They help shape our research priorities, review emerging data and guide the scientific direction of TruCBN™.

Anne Marie Morse, DO, FAASM

Anne Marie Morse, DO, FAASM

CLINICAL SLEEP ADVISOR

Board-certified neurologist and sleep medicine specialist who leads Child Neurology and Pediatric Sleep Medicine at Geisinger.

Judi Profant, PhD

Judi Profant, PhD

SLEEP SCIENCE & CLINICAL DEVELOPMENT ADVISOR

Clinical psychologist and behavioral sleep medicine specialist with extensive CNS drug-development experience across Janssen, Jazz, Teva and Supernus.

Mike McCormick, PhD

Mike McCormick, PhD

TRANSLATIONAL SCIENCE ADVISOR

MIT-trained chemist and former Scripps cannabinoid researcher specializing in cannabinoid biochemistry and translational science.

Leading through Science

From preclinical studies to large-scale human trials, our research is defining the future of cannabinoid therapeutics. We collaborate with leading institutions to explore how cannabinoids support sleep, neurological health, and overall well-being.

From our CEO

By advancing our understanding of cannabinoids and their interaction with human biology, we can unlock

a new class of therapeutic ingredients

. Our mission is to translate that science into accessible wellness solutions that contribute to a healthier, more hopeful world.

Redefining wellness

Together, we’re redefining what wellness means by breaking barriers, challenging convention, and proving that hope backed by science can change the world.

Find out how non-intoxicating cannabinoids could revolutionize the supplement industry.
Older woman hugging a family member outdoors

FloraWorks in the News

View All

Stay ahead in the world of cannabinoid science

Join our exclusive email list for the latest insights and breakthroughs.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.